Day: April 8, 2025

LA JOLLA, Calif., April 08, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced enrollment of the first patient in the NIH-funded Expanded Access Program (EAP) trial to evaluate MN-166 (ibudilast) in patients with Amyotrophic Lateral Sclerosis (ALS). This significant milestone marks the beginning of a critical trial aimed at providing access to MN-166 for ALS patients who are not eligible for the ongoing Phase 2/3 COMBAT-ALS trial. The EAP trial, funded by the National Institutes of Health (NIH) – Neurological Disorders and Stroke (NINDS)1-3, will evaluate the safety and efficacy of MN-166 in approximately 200 ALS patients. Dr. Yuichi Iwaki, President and CEO of MediciNova,...

Analyst Conference Call – 8:00 a.m. Pacific, Friday, May 9, 2025 BURNABY, British Columbia, April 08, 2025 (GLOBE NEWSWIRE) — INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) will release its first quarter financial results on May 8, 2025. The analyst conference call is scheduled for 8:00 am Pacific on Friday, May 9, 2025 and will feature a brief summary of financial results by Interfor management followed by a question and answer period with analysts.WHEN: Friday, May 9, 2025 at 8:00 am PTCALL DETAILS: 1-888-510-2154 (toll-free in North America)or  Webcast URL: https://app.webinar.net/8B42pJOZaKg  Information related to Interfor’s first quarter financial results will be available at www.interfor.com/investorsRECORDING PLAYBACK: The conference call will also be recorded for those unable to join the live...

BROOKLYN, New York, April 08, 2025 (GLOBE NEWSWIRE) — Titan Acquisition Corp (Nasdaq: TACHU) (the “Company”) announced today the pricing of its initial public offering of 24,000,000 units at $10.00 per unit. The units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “TACHU” beginning April 9, 2025. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “TACH” and “TACHW”, respectively. The underwriter has been granted a 45-day option to purchase up to an additional 3,600,000 units offered by the Company to cover over-allotments, if any. The offering is expected to close on April 10, 2025,...

WARREN, N.J., April 08, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a healthcare company with dedicated efforts in immunotherapy and artificial intelligence, today announced that Mittul Mehta, Chief Information Officer and Head of Tevogen.AI, presented at AI x Bio Philly, a premier event highlighting the convergence of artificial intelligence and life sciences in the Philadelphia region. Hosted by BioBuzz, BitsInBio, Atria, and Zetta, AI x Bio Philly brought together innovators, entrepreneurs, and investors for an evening of demos, discussion, and insight into how AI is shaping the future of biotechnology. Joined by Irene Rombell, CEO of BioCurie, David Latshaw II, PhD, CEO of BioPhy AI and Nathan Buchbinder, CSO and co-founder of Proscia, Mehta spoke during the AI Demos and Presentations...

CALGARY, Alberta, April 08, 2025 (GLOBE NEWSWIRE) — 2025 Annual Meeting of TransAlta Corporation Shareholders On Thursday, April 24, 2025, TransAlta Corporation (“TransAlta”) (TSX: TA) (NYSE: TAC) will hold its annual meeting of shareholders at 11:30 a.m. Mountain Time (1:30 p.m. Eastern Time) in a virtual-only meeting format via live audio webcast (https://meetings.400.lumiconnect.com/r/participant/live-meeting/400-164-661-424). The management proxy circular (available at https://transalta.com/investors/results-reporting/) provides detailed information about the business of the meeting and the voting process. TransAlta will only conduct the formal business of the meeting and there will not be a management presentation. First Quarter 2025 Conference Call TransAlta will release its first quarter 2025 results before markets open...

PANAMA CITY, April 08, 2025 (GLOBE NEWSWIRE) — Copa Holdings, S.A. (NYSE: CPA) announces the following events:Earnings Release – First Quarter 2025Date: May 7, 2025Time: After US market closeThis release will be available on our website: https://copa.gcs-web.com/financial-information/quarterly-results   Earnings Conference Call and Webcast  Date: May 8, 2025Time: 11:00 AM US ET (10:00 AM Local Time)Join by phone: https://register-conf.media-server.com/register/BIcb85f85fa26a4d56b9369d66c4fb6a5cWebcast (listen-only): https://copa.gcs-web.com/events-and-presentationsWe encourage our listeners to join the conference via webcast. To ensure a smooth experience, please access the website and complete registration/software installation prior to the scheduled start time. If you are unable to listen to or...

Bowie, MD., April 08, 2025 (GLOBE NEWSWIRE) — Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global owner, operator, provider, and manufacturer of electric vehicle (EV) charging equipment and services, announced today it received a letter from the Nasdaq Stock Market LLC (“Nasdaq”), dated April 2, 2025, informing the Company that it no longer complies with Nasdaq Listing Rule 5250(c)(1) because Blink had not filed its Form 10-K for the year ended December 31, 2024 (the “Form 10-K”) by the time period prescribed by Securities and Exchange Commission rules. Under Nasdaq’s Listing Rules, the Company must submit a plan to regain compliance with Nasdaq within 60 calendar days of the date of the letter. If Blink’s plan is accepted, then Nasdaq can grant an exception of up to 180 calendar days from the date that...